KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Payables (2016 - 2025)

Chemed (CHE) has 17 years of Payables data on record, last reported at $64.5 million in Q4 2025.

  • For Q4 2025, Payables rose 46.01% year-over-year to $64.5 million; the TTM value through Dec 2025 reached $64.5 million, up 46.01%, while the annual FY2025 figure was $64.5 million, 46.01% up from the prior year.
  • Payables reached $64.5 million in Q4 2025 per CHE's latest filing, up from $48.1 million in the prior quarter.
  • Across five years, Payables topped out at $77.2 million in Q3 2022 and bottomed at $40.3 million in Q1 2023.
  • Average Payables over 5 years is $55.2 million, with a median of $55.7 million recorded in 2021.
  • Peak YoY movement for Payables: soared 52.9% in 2021, then tumbled 44.5% in 2023.
  • A 5-year view of Payables shows it stood at $73.0 million in 2021, then plummeted by 42.64% to $41.9 million in 2022, then soared by 52.88% to $64.0 million in 2023, then tumbled by 31.06% to $44.1 million in 2024, then soared by 46.01% to $64.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $64.5 million in Q4 2025, $48.1 million in Q3 2025, and $50.9 million in Q2 2025.